Occult hepatitis B virus infection (Q27004224)

title

Occult hepatitis B virus infection (English)

0 references

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Min-Sun Kwak

series ordinal

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

27 December 2014

1 reference

World Journal of Hepatology

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

12

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

860-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

Clinical impact of occult hepatitis B virus infection in immunosuppressed patients

12 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Molecular mechanisms underlying occult hepatitis B virus infection

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Potential mutations associated with occult hepatitis B virus status

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Immunosuppression and HBV reactivation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatocellular carcinoma: the point of view of the hepatitis B virus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Diagnostic strategy for occult hepatitis B virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Prevalence of occult hepatitis B virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult Hepatitis B: Clinical Implications and Treatment Decisions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult hepatitis B virus infection: detection and significance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

A 2010 update on occult hepatitis B infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult hepatitis B virus infection: a covert operation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

The role of anti-core antibody response in the detection of occult hepatitis B virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Transfusion-transmitted hepatitis B virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis B and hepatocellular carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis B virus infection and transfusion medicine: science and the occult

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult hepatitis B virus infection in a North American adult hemodialysis patient population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Occult hepatitis B virus infection and its clinical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Noncytolytic control of viral infections by the innate and adaptive immune response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Long-lasting memory T cell responses following self-limited acute hepatitis B

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Studies of donors who transmit posttransfusion hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Therapy of occult hepatitis B virus infection and prevention of reactivation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

The clinical significance of occult HBV infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Mutations of the X region of hepatitis B virus and their clinical implications

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

"Occult" hepatitis B virus as source of infection in liver transplant recipients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

An overview of occult hepatitis B virus infection.

31 May 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection: a hidden menace?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

High prevalence of occult hepatitis B in Baltimore injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Characterization of occult hepatitis B virus strains in South African blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

A European perspective on the management of donors and units testing positive for hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection in pregnant woman and its clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

What is the clinical impact of occult hepatitis B virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I12.860

Occult hepatitis B virus infection and hepatocellular carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Prevalence of occult hepatitis B virus infection in hemodialysis patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Persistent occult hepatitis B virus infection: experimental findings and clinical implications

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Role of hepatitis B virus in hepatocarcinogenesis in alcoholics

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Lack of 'occult' hepatitis B virus infection in HIV-infected patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatitis B virus markers in anti-HBc only positive individuals

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269905

Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT

28 November 2018

1 reference

12 December 2020

Hepatitis B infection in patients with lymphomas

1 reference

12 December 2020

Occult hepatitis B virus infection

1 reference

12 December 2020

[Occult hepatitis B virus infection: transmission and reactivation]

1 reference

12 December 2020

Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders

1 reference

12 December 2020

[Definition, diagnosis, and prevalence of occult hepatitis B virus infection]

1 reference

12 December 2020

Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings

1 reference

12 December 2020

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology

1 reference

12 December 2020

Serological pattern ?anti-HBc alone?: Report on a workshop

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V6.I12.860

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

release_uhuw3pafnbavzclgvq4mbnjrq4

12 June 2020

Fatcat ID

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

25544873

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544873%20AND%20SRC:MED&resulttype=core&format=json